Nebivolol, a β-blocker abrogates streptozotocin-induced behavioral, biochemical, and neurophysiological deficit by attenuating oxidative-nitrosative stress: a possible target for the prevention of diabetic neuropathy
Crossref DOI link: https://doi.org/10.1007/s00210-017-1450-8
Published Online: 2018-01-11
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bhadri, Naini
Razdan, Rema
Goswami, Sumanta Kumar
Funding for this research was provided by:
Indian Council of Medical Research (45/21/2013/PHA-BMS)
License valid from 2018-01-11